4.7 Article

Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

Satoru Matsuda et al.

Summary: This study elucidated the distribution of residual disease and recurrence patterns in patients with ESCC responding to NAC. It was found that postoperative recurrence in responders occurred mostly as a solitary lesion in the regional field, indicating that additional chemoradiotherapy can eliminate residual tumor cells.

ANNALS OF SURGERY (2022)

Article Oncology

Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)

Chengqiang Li et al.

Summary: This study investigated the safety and efficacy of preoperative pembrolizumab combined with chemoradiotherapy in resectable oesophageal squamous cell carcinoma patients. The results showed that this treatment was safe and induced a pathological complete response in 55.6% of the tumors.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck et al.

Summary: The preoperative chemoradiotherapy regimen according to CROSS study has shown to have a long-term overall survival benefit for patients with locally advanced resectable esophageal or junctional cancer, with a stable effect observed up to 10 years of follow-up.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Surgery

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma A Randomized Clinical Trial

Hao Wang et al.

Summary: The study compared the safety and long-term survival outcomes of neoadjuvant chemoradiotherapy (nCRT) followed by minimally invasive esophagectomy (MIE) with neoadjuvant chemotherapy (nCT) followed by MIE for locally advanced esophageal squamous cell carcinoma (ESCC) patients. The initial results showed that nCRT followed by MIE had similar safety and better pathologic outcomes compared to nCT followed by MIE for treating locally advanced ESCC.

JAMA SURGERY (2021)

Article Medicine, General & Internal

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial

Huiyan Luo et al.

Summary: The addition of camrelizumab to chemotherapy significantly improved overall survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma. This treatment strategy could enhance the overall survival rate of patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice

Thomas W. Rice et al.

ANNALS OF CARDIOTHORACIC SURGERY (2017)

Article Gastroenterology & Hepatology

Global incidence of oesophageal cancer by histological subtype in 2012

Melina Arnold et al.

Article Gastroenterology & Hepatology

Extensive Mediastinal Lymphadenectomy During Minimally Invasive Esophagectomy: Optimal Results from a Single Center

Yaxing Shen et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2012)

Article Medicine, General & Internal

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Oncology

Are squamous and adenocarcinomas of the esophagus the same disease?

J. Ruediger Siewert et al.

SEMINARS IN RADIATION ONCOLOGY (2007)